10 research outputs found
Additional file 4 of Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study
Supplementary Material
Additional file 5 of Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study
Supplementary Material
Additional file 1 of Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study
Supplementary Material
Additional file 2 of Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study
Supplementary Material
Additional file 3 of Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study
Supplementary Material
Additional file 6 of Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study
Supplementary Material
Additional file 8 of Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study
Supplementary Material
Additional file 7 of Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study
Supplementary Material
Bolet铆n de Segovia: N煤mero 50 - 1924 abril 25
Copia digital. Madrid : Ministerio de Cultura. Subdirecci贸n General de Coordinaci贸n Bibliotecaria, 200
Modified Enzyme-Linked Immunosorbent Assay Strategy Using Graphene Oxide Sheets and Gold Nanoparticles Functionalized with Different Antibody Types
Gold
nanoparticles (GNPs) and graphene oxide (GO) sheets are excellent
nano carriers in many analytical methods. In this study, a modified
enzyme-linked immunosorbent assay (ELISA) strategy was developed using
antibody-functionalized GO sheets and GNPs. This modification significantly
reduced the limit of detection (LOD) and cost greatly of this assay.
The applicability of the method was demonstrated by detecting HSP70
in a human serum sample. This result suggests that the 3G-ELISA method
is feasible to detect an antigen in a complex mixture, and the LOD
is up to 64-fold and the cost is as low as one-tenth of the conventional
ELISA method